To understand how the complex embryonic expression pattern of the Msxl gene is produced a transgenic analysis of 13 kb of DNA around the Msxl locus was carried out. Most of the extensive expression pattern of the Msxl gene was reproduced in transgenics using the LacZ gene fused to 5 kb of Msxl 5' flanking DNA. Two enhancer domains were identified which produced this pattern. The distal element produced expression in the first arch and the nasal epithelium and was restricted to 240 bp. However, the proximal element which produced expression in superficial nasal epithelium, dorsal and ventral myotome, limb mesenchyme, eye, ear, roof plate, second arch, genital ridge and epiphysis, was contained in only 78 bp. © 1997 Elsevier Science Ireland Ltd.
Introduction
The Msx family of homeobox-containing genes is highly conserved and found in a diverse range of animal species including Hydra, sea urchins, Amphioxus, Ciona, Drosophila and all major classes of vertebrates (Hill et al., 1989; Robert et al., 1989; Takahashi and Le Douarin, 1990; Hewitt et al., 1991; Holland, 1991; Monaghan et al., 1991; Yokouchi et al., 1991; Bell. J.R. et al., 1993; Davidson, 1995) . Two of the family members, Msxl and Msx2, have been extensively studied in quail, chick and mouse embryos and the expression patterns are both temporally and spatially complex (Hill et al., 1989; Robert et al., 1989; Takahashi and Le Douarin, 1990; MacKenzie et al., 1991a; MacKenzie et al., 1991b; Monaghan et al., 1991; Yokouchi et al., 1991; MacKenzie et al., 1992) . Initially in development, Msxl is expressed in the mesoderm and ectoderm of the primitive streak, and later in the lateral surface ectoderm, lateral mesoderm and dorsal neuroepithelium (Hill et al., 1989; Robert et al., 1989; Takahashi and Le Douarin, 1990; . From this early expression pattern, complex, focused patterns of expression appear in diverse organs (for review see Davidson, 1995) . These include the developing limb * Corresponding author. Tel.: +44 131 3322471; fax: +44 131 3432620.
bud (Hill et al., 1989; Robert et al., 1989; Takahashi and Le Douarin, 1990; , the rim of the neural retina (Monaghan et al., 1991) , the endocardial cushions of the heart (Hill et al., 1989; Robert et al., 1989; Chan-Thomas et al., 1993) , the neural tube roof plate (Takahashi et al., 1992) and the face and head including the developing dental follicle and papilla, the cranial neuroectoderm, the forming skull bones, the choroid plexus, Rathke's pouch, and the otic vesicle (MacKenzie et al., 1991a; MacKenzie et al., 1991b; MacKenzie et al., 1992) .
Several embryonic organ systems, including the forming limbs and teeth, are shaped by the interaction of epithelial and mesenchymal components. The expression of Msxl is associated with morphogenesis in regions of inductive epithelial-mesenchymal interactions Robert et al., 1991; Krabbenhoft and Fallon, 1992; Lyons et al., 1992; Coelho et al., 1993; Jowett et al., 1993; Wang and Sassoon, 1995) . A role for this gene in cells which respond to diffusable factors mediating these epithelial-mesenchymal interactions is supported by grafting and tissue combination experiments. For example, in the limb the epithelial-derived apical ectodermal ridge (AER) induces expression of Msxl in underlying distal mesenchyme Robert et al., 1991; Coelho et al., 1993) . Epithelial-mesenchymal interactions that initiate tooth morphogenesis also control Msx gene expression. In co-culture experiments Msxl can be induced in non-dental mesenchyme by dental epithelium (Jowett et al., 1993) . The processes regulating Msxl expression are not uniform throughout the embryo and appear to vary according to location. Grafting experiments using limb and face mesenchyme demonstrate that although face mesenchyme expresses Msxl when grafted near limb epithelium, the reverse situation, limb mesenchyme near facial epithelium, does not result in expression (Brown et al., 1993) . Furthermore, within a single developing structure such as the limb different controlling mechanisms may operate to produce the pattern observed. Expression in distal limb mesenchyme is subject to controis that differ from those that regulate expression in proximal mesenchyme (Coelho et al., 1993) .
We have undertaken a study of the Msxl regulatory regions to aid in understanding the complexity of Msxl developmental expression. Although studies on the Msx2 promoter have found AER-specific enhancer domains (Liu et al., 1994; Sumoy et al., 1995) little is currently known of the elements in the promoter regions of the Msxl. Using transgenic embryos we studied the promoter properties of 13 kb around the Msxl locus including 6.5 kb of 5' flanking DNA, the Msxl intron and 5 kb of 3' flanking DNA. Analysis of this 13 kb has established that two separate domains within 4.9 kb 5' of the Msxl translational start site are responsible for the generation of much of the complex early expression of Msxl. Furthermore, we were able to restrict these elements to 240 bp and 78 bp domains and demonstrate their ability to act as enhancers, independent of their native promoter.
Results

A search for regulatory elements responsible for Msxl expression
We first analysed the expression patterns generated in transgenic mice using constructs 1 and 2 (Fig. 1A ) referred to as C1 and C2. These and all subsequent transgenics described were analysed at the Go generation. Both these constructs contained a region of DNA which included the first 44 codons of the Msxl gene and 4.8 kb of non-coding DNA extending 5' of the start site (Fig. 1A) . In addition, C1 contained 4 kb of 3' flanking DNA, the second Msxl exon and the single Msxl intron, in place of the SV40 polyadenylation site in C2. At embryonic day 10.5 (El0.5) both constructs produced LacZ expression in the face and limb anlagen in patterns described below (Fig.  1A,B) . Although expression levels of LacZ in eye, otic vesicle, epiphysis, roof plate and myotomes in C1 transgenics was undetectable (Fig. 2C) the rest of the expression pattern was similar for both constructs. It was concluded that no additional spatial promoter information exists in the 8 kb of DNA 3' of the Msxl start site.
Temporal and spatial analysis of C2
Since the spatial activity resided in the 4.9 kb of DNA immediately 5' of the gene we concentrated on C2. We studied the expression of the LacZ reporter gene in transgenics both spatially and temporally between embryonic days 9.5 and 12.5 (E9.5-E12.5) (Fig. 1B) .
In the face, Msxl expression is complex and a subset of this pattern is recreated by the transgene. In the pharyngeal arches at E9.5 /3-gal staining was detected in restricted domains in the mesenchyme of the first pharyngeal arch (Fig. 1B) . At El0.5 expression was restricted to lateral mesenchyme in the buccal half of the first arch, and was present in a medial stripe of mesenchymal cells in the second arch (Fig. 2B,H) . By E12.5 expression in the lower jaw was diffuse in mesenchymally derived tissues (Fig. 1B) . In the nasal pits at E9.5 expression appeared at the margin of the lateral epithelium (Fig. 1B) which by E 10.5 broadened as the nasal pit deepened (Fig. 1B and 2B,H). At E12.5 expression was undetectable except for a restricted domain in the external epithelium of the nostrils (Fig. 1B) . Although these facial patterns generated by C2 partially reflect the native Msxl expression ( Fig. 2A ) three important patterns failed to be expressed. First, Msxl transcripts are detectable in the mesenchyme of the nasal processes closely associated with nasal epithelial expression. Secondly, in the first arch, as Msxl expression decreases distally between El0.5 and Ei2.5, a second tooth-specific pattern is seen in the dental follicle and papilla. Finally, expression was not detected in the auri- The number of transient transgenic embryos generated which conform to a consistent pattern are expressed as a fraction of the total number of/3-gal staining embryos produced using a particular constmct in the table. In the table a plus or a minus indicates whether detectable LacZ expression was present in the structure indicated by an abbreviation at the top of the table. (B) Transgenic embryos produced with the constructs indicated in the bottom left hand comer stained with X-gal. The ages of transgenic embryos produced using C2 are indicated above each of the embryos. AER, apical ectodermal ridge; Lb, limb bud; 1, first pharyngeal arch; 2, second pharyngeal arch; Dm, dorsal myotome; Vm, ventral myotome; Ot, otic vesicle; Ey, eye; Ne, nasal epithelium; Ep, epiphysis; Mb, mid brain; Rp, roof plate of the neural tube; Gr, genital ridge; Dn, deep nasal epithelium; Sn, superficial nasal epithelium; blue boxes, LacZ gene; light blue boxes, human/3-gal-LacZ fusion; Hb, homeobox; Nc, NcoI; Nt, NotI; Bm, BamHI; H, HindlII; Ap, ApaI (the red Ap refers to the same ApaI site in both Fig. 1A and Fig. 3A) ; Sp, SphI. cular hillocks, surrounding the first pharyngeal cleft, which are destined to form the external ear from mesenchyme of the 2nd and 3rd arches ( Fig. 2A,B) (MacKenzie et al., 1991a; MacKenzie et al., 1992) .
The transgene was expressed in columnar epithelial-like cells of the ventral tips of the myotome (Fig. 2D ). This expression was first observed at E9.5, persisted until El0.5 ( Fig. 1B and 2C,D) but was undetectable by E12.5 (Fig.  1B) . We report here for the first time that the M s x l gene is expressed in the myotome (Fig. 2E) is also expressed in the dorsal aspect of the myotome (Fig.  2E ). The lack of expression of C1 and C2 in dorsal myotome will be discussed. In the neural tube/3-gal staining was detected in a faint band of cells running from the anterior neuropore caudally to the posterior neuropore corresponding to the neural tube roof plate. Expression by El0.5 (Fig. 1B) persisted in the dorsal neural tube, culminating rostrally in a spot at the site of the future epiphysis. With the exception of ectopic midbrain expression, the patterns produced by C2 in the CNS are similar to those previously reported for the native Msx 1 gene (Fig. 2E) (MacKenzie et al., 1991a; MacKenzie et al., 1992) .
Expression of the LacZ gene was also observed in the developing ear and eye. At E9.5 expression in the optic vesicle occurred (Fig. 2M ) in a limited rostral-dorsal domain ( Fig. 21 ) However, this expression, unlike Msxl expression, did not follow the formation of the ciliary body (Monaghan et al., 1992) but persisted in the same spot from E9.5 to E12.5 (Fig. 2M,N) . Initial transgene expression in the eye at E9.5 therefore precedes the time at which endogenous Msxl expression has been reported to occur (Monaghan et al., 1991) .
In the otic vesicle at El0.5 LacZ expression occurs in two domains in the rostral and the caudal aspects of the otic epithelium; the rostral domain lies at the apex of the otic cyst presumably destined to form the endolymphatic duct (Fig. 2K,L ), corresponding to a region where the Msxl gene is known to be expressed (unpublished data).
At E9.5 C2 was detectable throughout the forelimb bud mesenchyme ( Fig. 1B and 2G ). As the limb buds elongated at El0.5 and formed a recognisable hand plate between El0.5 and E12.5, distal expression was down-regulated (but was present in the AER) ( Fig. 1B and 2G ). LacZ expression remained in the proximal margin of the mesenchyme. By E12.5 LacZ expression was diffuse proximally with mesenchymal expression overlapping the first and last digit (Fig. 2G ). Early Msxl expression in the forming limb is very similar to the transgenic pattern before El0.5, showing no discernible apical-proximal difference (compare Fig. 2F ,G). By El0.5 Msxl expression is significantly different, residing in an area of the mesenchyme immediately underlying the AER. Only low levels of endogenous expression are detected in the AER. This expression pattern is different from the transgene which is expressed more proximally in a pattern in the mesenchyme unrelated to the AER. By E12.5 Msxl expression is also seen in interdigital tissue (Hill et al., 1989; , an expression pattern not reproduced by the transgene (compare Fig. 2F,G) .
It is clear that the patterns generated by C2 in transgenics are representative of aspects of the expression the native Msxl gene. Comparison between expression of the transgene and the native Msxl also suggests that the former may be driven by an enhancer that operates early in limb and eye development: Moreover, the transgenics fail to produce the entire facial and limb expression pattern detectable at the latest stage examined (E12.5). Other areas of Msxl expression not detectably produced by C2 included the forming dentition, Rathke's pouch, the forming skull bones, the heart and the choroid plexus. Because Msxl expression is undetectable in these areas it was concluded that C2 expression in the AER and the midbrain was ectopic.
Localisation of spatial expression elements
To define distinct spatial regulatory elements within the Msxl promoter, we generated a series of deletions of C2 (Fig. 1A) . To simplify the following deletion analysis transgenic embryos examined for LacZ expression were recovered at approximately El0.5. This developmental stage was chosen for two reasons. (1) All the structures in which Msxl comes to be expressed have formed and are still at an early stage of development. (2) After El0.5 expression from the transgenes is lost in certain areas.
Restriction of C2 with HindlII and SphI resulted in the generation of C3 and C4, respectively (Fig. 1A) . The spatial pattern generated by C3 and C4 were similar (Fig. 1B) . These two deletions consistently resulted in the loss of detectable /3-gal activity in the lateral nasal epithelium (except for a small frontal focus), the otic vesicle and the buccal mesenchyme of the first arch ( Fig. 1B and 2H) . Expression was retained in the neural tube roof plate, the putative epiphysis, the eye, the dorsal and ventral tips of myotomes, proximal limb mesenchyme and the AER. Both C3 and C4 also induced expression of/3-gal in the dorsal myotomes where native Msxl expression occurs (Fig. 1B) Slight expression was also seen in the mesenchyme of the first arch fusion site and the caudal second arch (Fig. 2H) .
ApaI digestion produced C5 which removed the distalmost 3.2 kb from C2 (Fig. 1A) and produced expression patterns in transgenic embryos inconsistent and different from those described for C2. We conclude that although the C5 may contain minimal promoter function, none of the elements necessary for the spatial pattern resided within this fragment.
An internal deletion of 1.7 kb from the C2 between the SphI and most proximal Apal restriction sites produced C6 (Fig. 1A) . This construct generated LacZ expression in the nasal epithelium, the otic vesicle (but not the endolymphatic duct) and pharyngeal cleft and first arch mesenchyme (Figs. 1B and 2H). We did not observe expression in the limb buds, the eye or otic vesicle, the second arch, the roof plate or the myotomes.
Since the entire Msxl expression pattern was not reproduced by the 4.9 kb promoter, two constructs, C7 and C8 (Fig. 1A) were produced in an attempt to determine whether more elements existed 5' of the NcoI site at the 5' end of C1 and C2. These constructs were driven by a heterologous promoter (the human/3-globin gene promoter) in combination with the LacZ reporter gene (Yee and Rigby, 1993) . C7 and C8 spanned 2.3 kb of DNA and extended the analysis 1.6 kb 5' of both constructs 1 and 2 (Fig. 1B) . C7 did not produce a consistent LacZ staining pattern but C8, which encompassed the area of DNA 5' of the HindIII site, reproduced the expression pattern of C6 (Fig. 1A) . These results suggest that no other spatial enhancer elements exist within 1.6 kb 5' of constructs 1 and 2.
The first stage of this analysis of the Msx I promoter region has shown that 4.9 kb of 5' DNA immediately flanking the Msxl gene is able to drive expression of a reporter gene in most areas of the mouse embryo in which the native gene is expressed. Furthermore, it has been shown that this pattern is under the control of a minimum of two separate regions of the promoter.
Analysis of the proximal element (PE)
We produced a series of constructs using the heterologous promoter to analyse the 1.7 kb region of DNA between the SphI and most proximal ApaI restriction sites for enhancer activity (Fig. 3A) . No consistent expression pattern was generated by C9 suggesting that most, if not all, of the proximal regulatory information is contained in C10.
The Msxl promoter component of C10 was cloned in the reverse orientation and 90 bp of 3' was inadvertently deleted during the cloning procedure (Fig. 3A) . However, C10 (containing 600 bp of the Msxl promoter) recreated the expression pattern previously observed for C3 and C4 (Fig. 3B ). In the pharyngeal arches, expression in the second arch was appropriate (Fig. 2H) ; however, there was additional expression in the first arch. A deletion analysis of C10 using internal NheI and ApaI sites to produce C11 and C 12 (Fig. 3A) failed to produce any consistently staining embryos, indicating that the spatial information contained in the construct lay 3' of the ApaI site. Two further constructs, C13 and C14, confirmed this by accurately reproducing the expression pattern produced by C10 (with the exception of the otic vesicle expression). It was surprising to note, however, that whilst little or no otic vesicle expression was produced by either C3, C4, or C10, strong expression in the otic vesicle, which closely resembles that produced by C2, was produced by C13 and C14 (Fig. 20,P and 3B) .
As both C13 and C14 produced a similar pattern and overlapped by 78 bp (Fig. 3A) it was concluded that the enhancer element responsible for generating the pattern resided within this 78 bp. This element was referred to as the proximal enhancer (PE) and lies 2198 bp 5' of the Msxl start site. The sequence of this region is presented in Fig. 4A . This sequence was searched for possible cis-acting transcription factor binding sites using the signal scan program (Prestridge, 1991) , but the search failed to identify binding sites that were either of significant apparent specificity or would bind transcription factors with expression patterns relevant to Msxl. The number of transient transgenic embryos generated which conform to a consistent pattern (see text) are expressed as a fraction of the total number of/3-gal-staining embryos produced using a particular construct. *, transgenic embryos which did not show LacZ staining but were shown to be LacZ transgenic by PCR. h/3gLacZ in a blue box refers tbthe human/3 globin promoter fused to the LacZ reporter gene. 1, first pharyngeal arch; 2, second pharyngeal arch; Ey, optic cup; Ot, otic vesicle; Rp, roof plate; Vm, ventral myotome; Dm, dorsal myotome; Ep, epiphysis; Gr, genital ridge; AER, apical ectodermal ridge; Nc, NcoI; H, HindlII; Ap, Apal (the red Ap refers to the same ApaI site in both Fig. 1A and Fig. 3A) ; Sp, SphI; Bg, BglI; Nh, NheI; Ac, AccI; Sc, SaclI. 
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Analysis of the distal element (DE)
We have demonstrated that deletion of the most 5" 710 bp of C2 resulted in loss of detectable/3-gal activity in the lateral nasal epithelium (except for a small frontal focus) and the buccal mesenchyme of the first arch. Moreover, we have shown that LacZ expression can be produced exclusively in these areas by C6 which includes the most 5' 710 bp. In order to try to achieve a better understanding of this region three further constructs were produced which placed fragments of DNA between the HindIII and NcoI site next to the heterologous promoter. C15 contained the distal-most 710 bp of C2 and reproduced expression in the lateral nasal epithelium and first pharyngeal arch characteristic of the distal element ( Fig. 2H and 3C,D) . However, in the pharyngeal arches, C15 was also expressed in a domain encompassing the rostral half of the first arch and part of the second arch ( Fig. 2H and 3D ). We found expression in several other unexpected areas, specifically in the AER, the facial ectoderm overlying the pharyngeal arches, and the dorsal ectoderm which we believe to be ectopic (Figs. 2H and 3D ). As the overlapping C16 produced no consistent spatial pattern of expression it was concluded that the region of C15 lying between SacII and Hind III contained no positive spatial regulatory elements. A final construct, C17, containing only 240 bp succeeded in exactly reproducing that pattern generated by C15 (Fig. 3C,D) .
These constructs demonstrated that the spatial information required for expression in the lateral first arch and the deep nasal epithelium produced by C2 and C6 resides within only 240 bp. This element was referred to as the distal element (DE) and lies 4006 bp 5' of the Msxl start site (Fig. 4B) . Sequence analysis of DE failed to identify binding sites of any transcription factors of interest.
Since both DE and PE are able to function outside the context of the native promoter and PE functions in the reverse orientation, we suggest that these elements are spatial enhancers. The inappropriate expression consistently generated by the construct analysed may arise from the uncovering of cryptic regulatory domains. ThuS, it is likely that other elements within the 4.9 kb promoter are present that further modify the expression of these two enhancers.
Discussion
Previous experiments suggest that transcriptional control of the Msxl gene is dependent on positional signals for the generation of the spatial expression pattern (Brown et al., 1993; Coelho et al., 1993) . To examine the complexity of the control of Msxl expression constructs composed of parts of the Msxl locus were linked to a reporter gene and used to generate transgenic embryos. These constructs included 6.5 kb of 5' and 4 kb of 3' Msxl flanking DNA and the Msxl intron. Our results suggest that at least 4.9 kb of DNA (contained in C2) is required to generate the Msxl gene expression pattern. Since neither C1 or C2 drove expression in all Msxl embryonic regions, we suggest that some regulatory elements lie outside the 13 kb of the Msxl locus studied.
C1 produced a less extensive Msxl-like expression pattern than C2. Removal of the 3' end, the second exon and the intron resulted in expression in the eye, the otic vesicle, the neural tube, and the myotomes, parts of the embryo in which the Msxl gene is expressed. In addition, dorsal myotome expression in transgenics was only produced following a second truncation to produce C3. One model to explain these observations is that while there are two detectable enhancer elements within the 13 kb of DNA analysed here, there are also negative regulatory elements which act on the PE in certain tissues. These negative modulators act as repressors on the PE in the largest constrncts when taken out of normal context. However, in its native configuration PE must be subject to additional regulation by other elements outside the 13 kb analysed here. Alternatively, the lack of expression from C1 as compared to C2 may reflect differences in post-transcriptional processing due to the different splice and poly adenylation sites contained in each construct.
Using a series of different constructs we have identified two distinct elements responsible for most of the observed C2 pattern; a proximal 78 bp domain (-2198 to -2276 PE, Figs. 3A and 4A) . and a distal 247 bp domain DE, Figs. 3C and 4B) . Further analysis of these domains showed that both PE and DE were able to activate transcription independent of other Msxl promoter elements and have the characteristics of enhancers.
Previous analysis of the human Msxl promoter in cell culture suggested that regulatory elements reside near the transcription start site (Shen et al., 1994) . However, in the mouse the most proximal 1.4 kb of the promoter showed no specific spatial activity and comparison of mouse sequence to that of the human sequence over this area showed no homology. It is possible that, rather than indicating a basic difference in the regulation of the two species, the human promoter elements described have roles in basal transcriptional activity.
Expression domains controlled by both elements
Expression of Msxl in the otic vesicle at El0.5 occurs in two domains: the caudal aspect, and the rostral aspect which later forms the endolymphatic duct. It is interesting that even though C2 transgenic animals show an organised otic vesicle expression pattern resembling the native Msxl pattern, subsequent deletions to produce C3, C4 and C10 result in the loss of this expression. However, when the PE element is further restricted to C13 and C14, removing the distal-most 225 bp, strong expression of the reporter resembling C2 occurs in the otic vesicle. Thus, expression of the C2 transgene in the otic vesicle seems to involve the interplay of the PE in combination with two other elements which serves to repress otic vesicle expression. One of these elements may be within the DE. We suggest that a negative regulatory element exists within the bounds of the distal 225 bp which actively represses expression of the transgene in the otic vesicle. Furthermore, this repression is regulated by the DE to produce the C2 expression pattern.
Expression in the mesenchyme of first and second pharyngeal arches required the participation of both elements to generate the overall pattern. Unlike the otic vesicle, the pharyngeal arch expression is a composite of two non-overlapping patterns regulated by DE and PE. DE is responsible for expression in the lateral buccal first arch mesenchyme. Expression in the caudal second pharyngeal arch mesenchyme appears to be due to PE. In addition, PE is responsible for expression in the first arch at the region of mid-line fusion. In the pharyngeal arches these elements operate in a mutually exclusive manner (compare Fig. 3B ,C, and Fig. 3D,E) . The involvement of both regulatory elements acting in discrete mesenchymal domains in each of the two pharyngeal arches underscores the complexity of regulating a single gene in tissue that is morphologically indistinguishable and of similar embryological origin.
PE as an 'early enhancer' in the eye and limb
The PE-containing constructs (C2, C3, C4, C10, C13 and C 14) contain elements responsible for early limb mesenchymal expression. In the early limb bud, the PE drives expression in the limb bud mesenchyme which persists until the formation of the hand plate at El0.5. At this point expression is confined to the anterior and posterior aspects of the limb and is expressed in a pattern showing no spatial relationship to the AER. Thus, in the limb bud mesenchyme between E9.5 and El0, expression of both the native Msxl gene and the C2 transgene are similar. However, at later stages when Msxl expression occurs in the distal mesenchyme, transgene expression occurs more proximally. One essential component of the signalling system that generates later Msxl limb expression in the distal mesenchyme is the AER Robert et al., 1992; Coelho et al., 1993) . These observations are consistent with studies suggesting that the generation of Msxl expression in the mouse limb bud is a two stage process consisting of early expression followed by a subsequent de novo expression driven by a second element. Studies of Msxl expression in limbless chick mutant limb buds which lack an AER also suggest that Msxl expression is biphasic; the gene is initially expressed in the early limb mesenchyme but is lost later at the time when the AER would normally form (Robert et al., 1991) . It has also been demonstrated that factors which induce distal Msxl expression in chick limb buds also repress more proximal expression (Coelho et al., 1993) . Thus, the PE element is participating in the early initial expression of Msxl in the forming limb which is down-regulated by a process that mediates subsequent AER-dependent distal expression. The LacZ pattern generated by the transgene in later embryos may reflect persistent expression from the PE element which cannot respond to downregulation.
It appears that the PE acts in a similar early fashion in the developing eye. LacZ expression driven by the PE first occurs at the nasal aspect of the optic vesicle at El0 coinciding spatially with the initiation of the ciliary body (Monaghan et al., 1991) . However, unlike native Msxl expression which subsequently resolves into a pattern that encompasses the entire ciliary body throughout its development (R. Holmes, personal communication; Monaghan et al., 1991) , the transgene does not produce a wider expression pattern but persists in the nasal aspect of the optic cup until E12.5 (Fig. 4M-O) . Thus, it is evident that the PE element controls the initial appearance of Msxl expression in both eye and limb formation which may require other elements for subsequent elaboration of the pattern.
Considering the range of different tissues in which the PE element drives LacZ expression we expected to find a series of cis-acting elements scattered throughout the promoter. We were surprised to discover that only 78 bp of DNA were responsible. There are several possible scenarios to explain this result. One involves the binding of a single activator protein, expressed in all the relevant tissues, to a single DNA binding site. Alternatively, the PE element may consist of a group of very close or overlapping binding sites to which relevant expression from the PE element can only occur when a certain combination of transcription factors bind within the 68 bp.
Control of expression in the forming musculature and roof plate
We have demonstrated that the Msxl gene is expressed in the dorsal and ventral extremities of the myotomes. PE contains regulatory elements required for this expression. In constructs which contain both enhancer elements (C1 and C2) the most distal 5' 710 bp which contains DE appears to down-regulate PE in dorsal myotome and roof plate. One explanation is that dorsal myotome and roof plate expression is regulated by some negative element close to or contained in DE which is under the influence of a dorsal-derived factor.
The MyoD gene produces a transcriptional activator of muscle-specific genes and is expressed chiefly in the myotome at El0.5 (Ashakra et al., 1995) . In cultured cells, expression of the MyoD gene has been shown to be repressed by Msxl expression (Woloshin et al., 1995; Song et al., 1992) . It is intriguing that the Msxl promoter drives the reporter gene in an area where one of its putative targets is expressed. This raises the possibility that MyoD expression may be delimited at the dorsal and ventral tips of the myotome by mechanisms involving the Msxl gene.
Conclusions
This study has demonstrated that the complex pattern of expression of the Msxl gene can be separated into at least three different spatial components. Two of these components have been examined here and are controlled by two separate enhancer elements. It is highly unlikely that these two enhancer domains are influenced by or interact with the same regulatory mechanisms since, with few exceptions, the nasal epithelium and the otic vesicle, quite different aspects of the overall expression pattern are generated by each. Thus, this study provides molecular evidence that spatial aspects of Msxl expression are separately controlled. The Msxl gene promoter is therefore a composite of elements that act both independently and in concert to generate the complex expression pattems reported for the gene.
Experimental procedures
Msxl promoter constructs
The genomic fragment containing the Msxl locus was isolated from the cosmid clone cosk2-5 obtained from a 129/St mouse genomic library cloned into pCosEMBL2 vector (Ehrich et al., 1987) . A 4.9 kb NcoI fragment was cloned from this cosmid into the NcoI site of pGEM-SZ (Promega) to produce pCosM',Ico5'. This fragment contains the Msxl translational start site plus 44 amino acids from the N-terminus. The remainder of the fragment is 5' of the start site (Fig. 1B) . The bacterial LacZgene from the vector pCHll0 (Pharmacia) was used as reporter. This LacZ gene was modified such that the 4.9 kb Msxl insert could be directly inserted in the frame. To accomplish this the pCH110 vector was modified by removing the HindlII to Kpnl fragment containing the LacZ start codon and was replaced with linker DNA containing an NcoI site. The linker was composed of the two complementary oligonucleotides: AGCTTCCGCCATGGTGGTAC and CAC-CATGGCGGA. The NcoI to BamHI fragment from pCHll0 containing the LacZ gene and the 4.9 kb NcoI Msxl fragment were cloned into the pGEMEX-I vector (Promega). This clone was called pH7LacZ. The insert could be released with SfiI and NotI restriction enzymes to give C2 (Fig. 1B) . Deletions of this construct were generated using HindlII (C3), SphI (C4) or ApaI (C5) (Fig. 1B) . The pH7LacT was generated by the introduction of a 10 kb SaclI/BamHI restriction fragment containing 3' exon 1 coding sequence, the Msx 1 intron, exon 2 and 4 kb of 3' flanking DNA into pH7LacZ in place of the SV40 poly adenylation site (Fig. 1A) . The insert could be released with SfiI and NotI restriction enzymes to give C1 (Fig. 1B) .The pH7LacAAS internal deletion construct was produced in two steps. The first step involved the coligation into NotI/NcoI digested pGEM-5Z of two fragments from pCoskNco5', such that the internal ApaI (the most 3' site) to SphI (see Fig. 1B ) was deleted. The two fragments used in the co-ligation were the 1.8 kb NotI (polylinker site 25 bp upstream of the NcoI site)/SphI (3' overhang removed) and the 1.6 kb ApaI (3' overhang removed)/NcoI fragment. This clone (pCoskAAS) was then digested with NcoI and the 3.2 kb insert was cloned into pH71acZ, replacing the initial original 4.9 kb NcoI. C6 was prepared by digestion of pH7LacAAS with SfiI and NotI. The heterologous promoter vectors pBGZ40-1229 and 1230, kindly provided by R. Krumlauf, consisted of the minimal human /3-globin promoter controlling the LacZ gene (Yee and Rigby, 1993) cloned in both orientations into the SmaI site of Bluescript KS (Stratagene). pacing and pHcc/3g were constructed by the cloning of an Apal and an HindlII fragment, respectively, into pBGZ40.1229 from the subclone pHx7Bm2.8a. This clone was derived from a 2.8 kb cosk2-5 BamHI fragment (isolated using the pNH/~g insert (see later) as probe) into the BamHI site of pGEM 1 lz (Promega). These constructs extended the analysis 1.6 kb 5' of the NcoI fragment cloned into pH71acZ (Fig. 1B) . Both C7 and C8 were released from pAa/3g and pHot/3g, respectively, by digesting with NotI and SalI. The following promoter constructs were produced by cloning restriction fragments from pCoskNco5' into the polylinker region of pBGZ40. pAA/3g (Fig. 1B) was produced by cloning the 972 kb AccI/ApaI blunt-end fragment (Fig. 1B) into HindIII site (5' overhang fill-in) of pBZ40-1230 and C9 was released by digestion with SalI and NotI. pAS/3g (Fig. IB) contained the 613 bp SphI/AccI (blunt-end) fragment (Fig.  IB) in the HindIII (5' overhang fill-in) site of pBGZ40-1230 and C10 was released by digesting with SalI and Not. Cll and C12 were produced by digesting C10 with ApaI/NotI and NheI/NotI, respectively, p30PE was produced by the cloning of a 225 bp SalI/ApaI fragment from pAS/3g into the SalI/ApaI site of pBGZ40-1229 and C13 was released by ApaI/NotI digestion, p29NB was produced by the cloning of a 238 bp NheI and BglI (end filled) fragment into the Spel and NotI (end filled) sites of pBGZ40 1229. C14 was released from p29NB by digesting with SaclI/SalI. pNH/~g (Fig. 1B) contained the NotI (polylinker site 25 bp upstream of the NcoI site)/ HindlII (5' overhang fill-in) 756 bp fragment. This fragment was cloned into the NotI and SpeI (5' overhang fillin) site of pBGZ40-1229. C15 was released from pNH/3g by digesting with Sail and NotI. pSNbg was produced by the cloning of an 821 bp SaclI/NheI fragment into the SaclI/SpeI site of pBZ40-1229 and C16 was released by digestion with Sail SacI. p29DE was produced by the cloning of a 340 bp blunt-ended SaclI fragment from pNH/3g into the HindlIl (5' overhang fill-in) of pBGZ40 1229 and C17 was released by digestion with ApaI and NotI.
All reactions to give blunt-end restriction sites used T4 polymerase (Boehringer) essentially as described by Sambrook et al., 1989 . All restriction enzymes were used according to manufacturer's description.
Transgenic embryos
Transgenic mouse embryos were generated as described (Hogan et al., 1986) . DNA constructs at a concentration of 2 ng/tzl were injected into one-cell embryos derived from superovulated (CBA x C57BL/6)F1 females. Injected eggs were transferred into pseudopregnant females (Swiss strain). Embryos were harvested at the appropriate number of days after transfer (transfer day was designated E0.5) and assayed for 13-gal activity (Sanes et al., 1986) . Staining for/3-gal in transgenic embryos was stopped at three time points, 1 h, 3 h, and overnight incubation. To assay the transcriptional activity of this region of the Msxl promoter, transgenic embryos at the Go generation were analysed.
Histological sections
Stained embryos were washed twice in phosphate-buffered saline (PBS) and left overnight in 4% sucrose/PBS. Embryos were then incubated for 6 h in 20% sucrose/PBS, then transferred into BSG (14% bovine serum albumen, 20% sucrose, 0.5% gelatin in PBS) and shaken gently overnight. Next day the embryos were embedded in fresh BSG mixed with 2.5% gluteraldehyde and 100 ~m thick sections cut using a Vibrotome series 1000.
Sequence analysis
Sequence was generated as per Maniatis (1989) , and double stranded template was denatured as described (Winship, 1989) . DNA sequence was analysed with a Sun workstation.
